CAS: 1361227-90-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
JH-RE-06 REF: TM-T15611CAS: 1361227-90-8 | 99.24% | 268.00 €~1,803.00 € | Mon 06 May 24 | |
JH-RE-06 REF: 3D-LEC22790CAS: 1361227-90-8 | Min. 95% | To inquire | Mon 17 Jun 24 |
JH-RE-06
CAS:1361227-90-8
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is …
Formula:
C20H16Cl3N3O4
Purity:
99.24%
Color and Shape:
Solid
Molecular weight:
468.72
Ref: TM-T15611
1mg | 268.00 € | |
5mg | 433.00 € | |
10mg | 632.00 € | |
25mg | 994.00 € | |
50mg | 1,328.00 € | |
100mg | 1,803.00 € | |
1ml*10 (DMSO) | 430.00 € |
Estimated delivery in United States, on Monday 6 May 2024
JH-RE-06
CAS:1361227-90-8
JH-RE-06 is a drug that can be used to treat cancer. It is an inhibitor …
Formula:
C20H16Cl3N3O4
Purity:
Min. 95%
Molecular weight:
468.72 g/mol
Ref: 3D-LEC22790
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024